Altaris Capital Partners completed the acquisition of 3M's drug delivery business for c. $650m.

Altaris Capital Partners, an investment firm, completed the acquisition of a drug delivery business of 3M, an American multinational conglomerate, for c. $650m. Following the acquisition, Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, launched as an independent company. "We are excited to be partnering with 3M and the Kindeva team in this transaction. We believe Kindeva is well-positioned to build on its successful track record as a leading provider of drug delivery technologies," George Aitken-Davies, Altaris Managing Director.